FQ
JNCE

First Quadrant’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

First Quadrant’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-37,800
Closed -$257K – 563
2021
Q2 		$257K Buy
+37,800
New +$257K 0.03% 317